stockrowAkebia Therapeutics, Inc. (AKBA) vs Glass House Brands Inc. (GLAS)
- Akebia Therapeutics, Inc. AKBA 0.41 −4.65%
- Glass House Brands Inc. GLAS 2.17 −2.69%
Akebia Therapeutics, Inc. and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. Glass House Brands Inc. is the larger, with a market value of $172.7M against $117.9M — 1.5× the size. Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: −12.4% against −15.4%. Akebia Therapeutics, Inc. has the higher net margin (−22.6% vs −36.2%) and the higher return on invested capital (0.00% vs −23.4%). Across the 17 metrics below, Akebia Therapeutics, Inc. leads on 12 and Glass House Brands Inc. on 5.
Valuation
Profitability
| Metric | AKBA | GLAS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 78.90% | 31.97% | 53.51% |
| Operating margin | (15.74%) | (23.18%) | 0.00% |
| Net margin | (22.60%) | (36.19%) | (2.45%) |
| Free cash flow margin | 7.03% | (20.78%) | 0.00% |
| Return on equity | (143.83%) | (74.02%) | (0.80%) |
| Return on assets | (12.62%) | (19.78%) | (1.67%) |
| Return on invested capital | 0.00% | (23.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack